SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+19.54%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$269M
AUM Growth
+$269M
(+36%)
Cap. Flow
+$44.8M
Cap. Flow
% of AUM
16.7%
Top 10 Holdings %
Top 10 Hldgs %
31.54%
Holding
57
New
12
Increased
18
Reduced
17
Closed
7
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$8.35M |
| 2 |
Amgen
AMGN
|
$6.03M |
| 3 |
Centene
CNC
|
$5.97M |
| 4 |
Biogen
BIIB
|
$5.94M |
| 5 |
Zimmer Biomet
ZBH
|
$5.24M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$5.18M |
| 2 |
Becton Dickinson
BDX
|
$5.06M |
| 3 |
CELG
Celgene Corp
CELG
|
$4.97M |
| 4 |
Alcon
ALC
|
$3.11M |
| 5 |
Quest Diagnostics
DGX
|
$2.4M |
Sector Composition
| 1 | Healthcare | 99.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
IQVIA
IQV
$32.4B
| $5.41M | 2.01% |
35,000
+5,000
| +17% | +$773K |
|
27
Zoetis
ZTS
$69.3B
| $5.29M | 1.97% |
40,000
+10,000
| +33% | +$1.32M |
|
28
Stryker
SYK
$150B
| $5.25M | 1.95% |
25,000
| – | – |
|
|
29
Zimmer Biomet
ZBH
$21B
| $5.24M | 1.94% |
+35,000
| New | +$5.24M |
|
30
Abbott
ABT
$231B
| $5.21M | 1.93% |
60,000
-20,000
| -25% | -$1.74M |
|
31
Johnson & Johnson
JNJ
$427B
| $5.11M | 1.9% |
+35,000
| New | +$5.11M |
|
32
Medtronic
MDT
$119B
| $5.11M | 1.9% |
45,000
+5,000
| +13% | +$567K |
|
33
AbbVie
ABBV
$372B
| $4.43M | 1.64% |
+50,000
| New | +$4.43M |
|
34
Labcorp
LH
$23.1B
| $4.23M | 1.57% |
25,000
-5,000
| -17% | -$846K |
|
35
Align Technology
ALGN
$10.3B
| $4.19M | 1.55% |
+15,000
| New | +$4.19M |
|
36
Smith & Nephew
SNN
$16.3B
| $3.61M | 1.34% |
+75,000
| New | +$3.61M |
|
37
Edwards Lifesciences
EW
$47.8B
| $3.5M | 1.3% |
15,000
-10,000
| -40% | -$2.33M |
|
38
Incyte
INCY
$16.5B
| $3.49M | 1.3% |
40,000
-15,000
| -27% | -$1.31M |
|
39
Illumina
ILMN
$15.8B
| $3.32M | 1.23% |
+10,000
| New | +$3.32M |
|
|
40
Quest Diagnostics
DGX
$20.3B
| $2.94M | 1.09% |
27,500
-22,500
| -45% | -$2.4M |
|
41
Sarepta Therapeutics
SRPT
$1.78B
| $2.9M | 1.08% |
22,500
+7,500
| +50% | +$968K |
|
42
Avantor
AVTR
$9.18B
| $2.72M | 1.01% |
+150,000
| New | +$2.72M |
|
|
43
Alcon
ALC
$39.5B
| $2.55M | 0.95% |
45,000
-55,000
| -55% | -$3.11M |
|
|
HRC
44
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.26M | 0.84% |
19,900
-10,100
| -34% | -$1.15M |
|
|
SGEN
45
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.23M | 0.83% |
19,500
-500
| -3% | -$57.1K |
|
|
BLUE
46
DELISTED
bluebird bio
BLUE
| $1.76M | 0.65% |
+20,000
| New | +$1.76M |
|
47
CRISPR Therapeutics
CRSP
$4.71B
| $1.52M | 0.57% |
+25,000
| New | +$1.52M |
|
|
BPMC
48
DELISTED
Blueprint Medicines
BPMC
| $1.48M | 0.55% |
18,520
-1,480
| -7% | -$119K |
|
|
SAGE
49
DELISTED
Sage Therapeutics
SAGE
| $1.08M | 0.4% |
15,000
+5,000
| +50% | +$361K |
|
50
Agilent Technologies
A
$35.7B
| – | – |
-10,000
| Closed | -$766K |
|